Enlivex Therapeutics
ENLV
ENLV
10 hedge funds and large institutions have $5.53M invested in Enlivex Therapeutics in 2016 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
10
Holders Change
-2
Holders Change %
-16.67%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
5
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$2.82M |
2 |
VKH
Virtu KCG Holdings
New York
|
+$28.1K |
Top Sellers
1 |
VAM
Visium Asset Management
New York
|
-$325K |
2 |
KCM
Knoll Capital Management
Miami,
Florida
|
-$217K |
3 |
SIM
Spark Investment Management
New York
|
-$108K |
4 |
OC
Oppenheimer & Co
New York
|
-$40.7K |
5 |
UBS Group
Zurich,
Switzerland
|
-$12.5K |